HIV Seropositivity Clinical Trial
Official title:
Relationship Between Neuromuscular Fatigue, Perceived Tiredness and Level Of Physical Activity of Patients Living With HIV
Fatigue is a common symptom in people living with HIV (PHAs) that affects all aspects of life
. This would include physical deconditioning, a reduction in motor skills . Numerous studies
show that physical activity brings benefits for the quality of life of PHAs . However, due to
the predominantly reported fatigue, many PHAs are not physically active enough in relation to
these recommendations. While it is recognized that fatigue is predominant in PHAs, this
complaint has mainly been subjectively quantified and has rarely been physically objectified
a better understanding of the relationship between neuromuscular fatigue, perceived fatigue
and the level of physical activity of PHAs is needed in line with current work on integrating
fatigue.
OBJECTIVES This project, based on an integrative (eg, neurophysiological and psychological)
approach to fatigue, aims to better explain and prevent the vicious circle of physical
deconditioning in PHAs by examining the relationships between neuromuscular fatigue,
perceived fatigue, Physical activity of patients.
The main objective of the study will be to compare the characteristics of neuromuscular
fatigue in physically active or inactive PHAs.
The secondary objective will be to examine the relationship between neuromuscular fatigue,
level of physical activity and perceived physical fatigue of PHAs.
CONDUCT OF THE STUDY Cross-sectional comparative study without individual benefit for the
patient. Monocentric test to quantify and relate neuromuscular fatigue, perceived physical
fatigue, and physical activity level. The main inclusion criteria for this study are: PLHIV
aged between 40 and 60; Diagnosed and treated with antivirals after 1996, irrespective of the
value of the viral load and CD4 lymphocyte level at the last assessment; The physical
activity level of the patients will be evaluated before the start of the study in order to
constitute two distinct groups
- Principal evaluation criterion: Investigation of the neurophysiological characteristics
of fatigue will be done by recording the capacity to produce force at the level of the
extensor muscles of the knee under conditions of voluntary contractions and evoked by
magnetic stimulation at the level of Femoral nerve.
- Secondary evaluation criteria: the investigation of the perceived fatigue will be done
by a valid psychometric questionnaire.
RATIONAL Fatigue is a common symptom in people living with HIV (PHAs) that affects all
aspects of life . This would include physical deconditioning, a reduction in motor skills .
Numerous studies show that physical activity brings benefits for the quality of life of PHAs.
However, due to the predominantly reported fatigue, many PHAs are not physically active
enough in relation to these recommendations. While it is recognized that fatigue is
predominant in PHAs, this complaint has mainly been subjectively quantified and has rarely
been physically objectified. , a better understanding of the relationship between
neuromuscular fatigue, perceived fatigue and the level of physical activity of PHAs is needed
in line with current work on integrating fatigue.
OBJECTIVES OF THE STUDY This project, based on an integrative (eg, neurophysiological and
psychological) approach to fatigue, aims to better explain and prevent the vicious circle of
physical deconditioning in PHAs by examining the relationships between neuromuscular fatigue,
perceived fatigue, Physical activity of patients.
The main objective of the study will be to compare the characteristics of neuromuscular
fatigue in physically active or inactive PHAs.
The secondary objective will be to examine the relationship between neuromuscular fatigue,
level of physical activity and perceived physical fatigue of PHAs.
CONDUCT OF THE STUDY Cross-sectional comparative study without individual benefit for the
patient. Monocentric test to quantify and relate neuromuscular fatigue, perceived physical
fatigue, and physical activity level. The main inclusion criteria for this study are: PLHIV
aged between 40 and 60; Diagnosed and treated with antivirals after 1996, irrespective of the
value of the viral load and CD4 lymphocyte level at the last assessment; The physical
activity level of the patients will be evaluated before the start of the study in order to
constitute two distinct groups: (a) a group of patients considered as physically active (SAP>
22) and (b) a group of patients considered as Physically inactive (SAP <15). Confirmed by
blood diagnosis. Those who have recently stopped their antiretroviral treatment and / or
their medical follow-up and who have a progressive recovery of their infection and those
affected by other health conditions marked by fatigue will be excluded.
- Principal evaluation criterion: Investigation of the neurophysiological characteristics
of fatigue will be done by recording the capacity to produce force at the level of the
extensor muscles of the knee under conditions of voluntary contractions and evoked by
magnetic stimulation at the level of Femoral nerve.
- Secondary evaluation criteria: the investigation of the perceived fatigue will be done
by a valid psychometric questionnaire.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03661203 -
Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM
|
||
Completed |
NCT00381212 -
A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05983536 -
The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)
|
||
Recruiting |
NCT04832477 -
Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US
|
N/A | |
Active, not recruiting |
NCT04044586 -
HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)
|
||
Completed |
NCT03218839 -
Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males
|
N/A | |
Active, not recruiting |
NCT00797030 -
Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
|
Phase 4 | |
Recruiting |
NCT04088916 -
Proviral DNA as a Target for HIV-1 Resistance Analysis
|
||
Completed |
NCT03367130 -
Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal
|
N/A | |
Completed |
NCT04849767 -
National Survey About Trajectory and Life Conditions of HIV Trans People in France
|
||
Completed |
NCT05674682 -
Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study
|
N/A | |
Recruiting |
NCT05174234 -
Precariousness and Sexual Vulnerability of People From Haiti Living With or Without HIV in French Guiana
|
||
Completed |
NCT00130819 -
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants
|
Phase 2 | |
Active, not recruiting |
NCT04706624 -
Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics
|
N/A | |
Recruiting |
NCT03858478 -
Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST
|
Phase 4 | |
Completed |
NCT02154971 -
Assessment of Age-related Hearing Loss in HIV-1 Patients
|
||
Recruiting |
NCT03311945 -
Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM
|
Phase 3 | |
Recruiting |
NCT03333083 -
Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
|
Phase 3 | |
Recruiting |
NCT03795415 -
ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali
|
||
Completed |
NCT02003989 -
Revealing Increased Axonal Loss in Treated HIV Patients
|
N/A |